ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
IPILIMUMABUM
Active substance (INN) · ATC L01FX04 · 1 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| L01XC11 | IPILIMUMABUM | In force | medicine of the protocol | C2-P3 | NO |
| L01XC11-17 | NIVOLUMABUM + DCI IPILIMUMABUM | In force | medicine of the protocol | C2-P3 | NO |
| L01XC17 | NIVOLUMABUM | In force | mentioned in the text | C2-P3 | NO |
| L01XE15 | VEMURAFENIBUM | In force | mentioned in the text | C2-P3 | YES |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| YERVOY 5 mg/ml | CONC. PT. SOL. PERF. | 5mg/ml | BRISTOL-MYERS SQUIBB PHARMA EEIG - IRLANDA | L01FX04 | PR |